Background miRNAs, a class of small endogenous RNAs, are one of the essential
biopharmaceuticals which are in commercial spans as next-generation medicine in recent …

Lung cancer is the most common cancer worldwide. Up to 85% of lung cancer cases are
diagnosed as non-small cell lung cancer (NSCLC). The effectiveness of NSCLC treatment is …

Background: miRNA, a small non-coding RNA molecule containing about 22 nucleotides,
functions in RNA silencing and post-transcriptional regulation of gene expression. With …

Simple Summary Over the last few years, we have witnessed incredible advancements in
anti-tumor drug development. microRNAs, a class of small non-coding RNAs dysregulated …

MiRNAs, small non-coding RNA molecules, were recognized to be associated with the
incidence and development of diverse neoplasms. MiRNAs were small non-coding RNAs …

Simple Summary Pancreatic cancer is the fourth leading cause of cancer death in the United
States and over 90% of the patients suffer from pancreatic ductal adenocarcinoma (PDAC) …

Background & Objective: The incidence of non-small cell lung cancer (NSCLC) has been
rising over the past several decades. Despite various therapeutic regimens and modern …

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) have led to a
substantial improvement in the prognosis of lung cancer patients by explicitly targeting the …

Lung cancer is the second most common and the leading cause of cancer related deaths
globally. Tyrosine Kinase Inhibitors (TKIs) are among the common therapeutic strategies in …

MDR1 is highly expressed in MDR A2780DX5 ovarian cancer cells, MDR SGC7901R
gastric cancer cells and recurrent tumours. It pumps cytoplasmic agents out of cells, leading …